FDA halts im­ports of sev­er­al Sun Phar­ma drugs made in In­dia due to out­stand­ing qual­i­ty is­sues

A drug man­u­fac­tur­ing site that has gar­nered a lot of at­ten­tion from the FDA this year has been hand­ed an im­port alert from the US reg­u­la­tor, block­ing cer­tain drugs from en­ter­ing the coun­try.

Ac­cord­ing to the FDA, Sun Phar­ma’s plant in the city of Halol, In­dia has been giv­en an im­port alert, as of yes­ter­day, which means that the reg­u­la­tor has enough ev­i­dence to de­tain prod­ucts with­out ex­am­i­na­tion and refuse their en­try in­to the US mar­ket un­til the is­sues are cor­rect­ed and the fa­cil­i­ty is com­pli­ant with cGMP.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER